Evidence map›Paper›PMID 40641984›Full record

ArticleFrontiers in medicine2025

Correction: Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis.

Mahnoor Mir, Felipe Soto, Pedro Antonio Amezcua Gomez, Rodrigo Del Rio Arroyo, Adarsh Suresh, Amber Su, Qiong Gan, John Stewart, Roberto Adachi, Diwakar D Balachandran and 18 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Mahnoor Mir *Division of Critical Care, Pulmonary, and Sleep Medicine, McGovern Medical School at UTHealth Houston, Houston, TX, United States.
Felipe Soto *School of Medicine, Tecnológico de Monterrey, Monterrey, Mexico.
Pedro Antonio Amezcua GomezSchool of Medicine, Tecnológico de Monterrey, Monterrey, Mexico.
Rodrigo Del Rio ArroyoSchool of Medicine, Tecnológico de Monterrey, Monterrey, Mexico.
Adarsh SureshTexas A&M School of Medicine, Houston, TX, United States.
Amber SuDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Qiong GanDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
John StewartDepartment of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Roberto AdachiDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Diwakar D BalachandranDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Lara BashouraDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Roberto F CasalDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Burton F DickeyDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
George A EapenDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Scott E EvansDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Horiana GrosuDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Carlos A JimenezDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Julie LinDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
David E OstDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Bruce F SabathDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Vickie R ShannonDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Aung NaingDepartment of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Jianjun GaoDivision of Cancer Medicine, Department of Genitourinary Medical Oncology, Houston, TX, United States.
Jia WuDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Karthik SureshDepartment of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, MD, United States.
Saadia A FaizDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Mehmet AltanDepartment of Thoracic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Ajay SheshadriDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.3389/fmed.2025.1582714.].

Indexed as

BAL (bronchoalveolar lavage)cell percentageeosinophiliaimmune check inhibitor (ICI)lymphocytosispneumonitis

Identifiers

PMID40641984
PMCPMC12241143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.